Birdwatch Note Rating
2023-03-17 03:26:56 UTC - HELPFUL
Rated by Participant: 33ADA05430AF9F021EF972F9B30E425AA149B49E8E336B8CF12DC4004438B564
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details